Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every ...

Another biotech startup revealed plans Friday evening for an initial public offering, making it the sixth startup to list new ...

A small ge­net­ic test­ing start­up backed by Pe­ter Thiel’s Founders Fund and Red­dit co-founder Alex­is Ohan­ian’s 776 Fund ...

Despite largely exiting oncology, Sanofi continues to reap the benefit of its multiple myeloma treatment Sarclisa. The FDA on ...

This week, a letter surfaced in which Eli Lilly asked for a patient to release medical information so it could contact her ...

The US' Health Resources and Services Administration threatened Johnson & Johnson with fines for unilaterally reshaping the ...

Amer­i­cans can now vac­ci­nate them­selves against the flu with­out the as­sis­tance of a health­care work­er.

The Federal Trade Commission said that it is suing the three major US pharmacy benefit managers over their role in the ...

Yuhan and Johnson & Johnson Innovative Medicine (JJIM), formerly known as Janssen, ended a research project after securing ...

After a second review, the FDA approved Zevra Therapeutics’ treatment for Niemann-Pick disease type C, a progressive rare ...

An early-stage biotech investor called YK Bioventures plans to raise $100 million, according to an SEC filing on Wednesday.

Novo Nordisk's $1 billion bet last year on a small Canadian biotech could expand the Danish drug giant's arsenal of obesity medicines, but it will first have to address safety concerns. On Friday, Nov ...